MedPath

A Clinical Trial To Study The Effect Of Tila Nala Kshara For The Treatment Of Stones Of Urinary System.

Phase 2
Conditions
Health Condition 1: N209- Urinary calculus, unspecified
Registration Number
CTRI/2020/09/027911
Lead Sponsor
Shubham Bhagat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient Of Mutrashmari Of Size Minimum 4mm To Maximum 20mm

Patients Of Obstructive As Well As Non Obstructive Pathology With Normal KFT

Patients Of Mutrashmari With Renal And/Or Ureteric And/Or UVJ Calculus

Exclusion Criteria

Patients Of Obstructive Pathology With Changes Of Severe Hydronephrosis In USG

Patient Is Having Uncontrolled Diabetes And/Or Hypertension And/Or Asthma And Other Major Systemic Illness

Impaired Renal Function

Pregnant And Lactating Mother

Urinary Calculi Having Size More Than 20mm

Kshara Ayogya Vyadhi

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find out how this drug reduces the size of Mutrashmari or promotes its expulsionTimepoint: 7 Days
Secondary Outcome Measures
NameTimeMethod
To establish the better medicinal alternative in the management of Mutrashmari <br/ ><br>To find out whether this drug shortens the duration of treatment of Mutrashmari than other drugsTimepoint: 7days
© Copyright 2025. All Rights Reserved by MedPath